UnratedDrug recall · FDA · Published September 24, 2021
Eli Lilly Glucagon Kit Recalled: Subpotent Drug Risk
Eli Lilly recalls Glucagon Emergency Kits for low blood sugar due to subpotent drug content. The vial contains liquid instead of powder, reducing effectiveness. No remedy specified in official notice.
SUBPOTENT DRUG: Vial contained a liquid substance, instead of the expected powder substance. There was also a lack of full drug effect upon administration.
Take action
Contact the company
📍Recalling firmEli Lilly & Company839 S Delaware St · Indianapolis, IN 46225-1782
“Eli Lilly Glucagon Kit Recalled: Subpotent Drug Risk.” GovInfoNow, updated August 18, 2026. https://govinfonow.com/recall/35839-eli-lilly-glucagon-kit-recalled-subpotent-drug-risk. Based on FDA recall #D-0009-2022 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0009-2022%22&limit=1).
Eli Lilly & Company voluntarily recalled Glucagon Emergency Kits for low blood sugar on Sept. 24, 2021, after the FDA announced the vials contained a liquid substance instead of powder, resulting in a lack of full drug effect. The recall affects 19,174 syringes distributed nationwide and in Canada, Argentina, Costa Rica, and Mexico.
How to tell if you have it
Brand: Eli Lilly
Product: Glucagon Emergency Kit for Low Blood Sugar, Glucagon for Injection, 1 mg per vial; Diluent for Glucagon, 1 mL syringe
NDC: 0002-8031-01
Lot #: D239382D
Exp. Date: April 2022
The hazard
The vials contained a liquid substance, instead of the expected powder substance, leading to a lack of full drug effect upon administration. The FDA classified this as a Class I recall due to the subpotent drug risk.
Context
GovInfoNow's records show Eli Lilly & Company has 3 other recalls on record since June 29, 2021. Other recent recalls of similar products include Lupin Glucagon Emergency Kit Recall (June 23, 2026) and Gasco Isopropyl Alcohol 70% Recall (May 29, 2026).
How to tell if you have this one
Check for the Glucagon Emergency Kit with the NDC code 0002-8031-01. The kit was sold with the lot number D239382D and expired April 2022.
Brand
Eli Lilly
Category
Drug
Based on the official FDA remedy
What to do — step by step
Check Kit Details
Look for the NDC code 0002-8031-01 on the kit label.
Where it went and when
Where it was distributed
Distributed nationwide, and outside the U.S.
Nationwide
Not listed
FDA distribution: “Nationwide with the USA and Puerto Rico; Canada, Argentina, Costa Rica, Mexico” States read from FDA’s own wording; “not listed” means the notice does not name it.
Distributed nationwide, and outside the U.S.
Recall timeline
FDA terminated this recall 3 years after the firm started it.
1Firm started the recall
2FDA classified it Class I
3Published in FDA’s Enforcement Report
4FDA terminated the recall
Dates from the agency record only; steps without a date are left out.
The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.
Official source: FDA Recall #D-0009-2022 (September 24, 2021) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-0009-2022 to see it in context.
Plain-language summary written by qwen3:4b on August 18, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.